1 story in the last 7 days
The latest inflammatory diseases news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks inflammatory diseases across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Bionyra Pharma launched with a €143 million oversubscribed Series A round co-led by Jeito Capital and Sofinnova Partners. The clinical-stage biopharma company develops next-generation biologics for immune-mediated inflammatory diseases. Sanofi Ventures and other investors also participated in the financing.
Summaries by ByteBrief